1. Home
  2. ACU vs KRRO Comparison

ACU vs KRRO Comparison

Compare ACU & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$45.63

Market Cap

175.3M

ML Signal

HOLD

Logo Korro Bio Inc.

KRRO

Korro Bio Inc.

HOLD

Current Price

$13.94

Market Cap

150.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
KRRO
Founded
1867
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
150.0M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
ACU
KRRO
Price
$45.63
$13.94
Analyst Decision
Strong Buy
Buy
Analyst Count
1
12
Target Price
$50.00
$34.80
AVG Volume (30 Days)
15.2K
171.5K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
1.39%
N/A
EPS Growth
1.63
N/A
EPS
2.49
N/A
Revenue
$196,541,816.00
$6,392,000.00
Revenue This Year
$5.72
N/A
Revenue Next Year
$5.19
N/A
P/E Ratio
$18.48
N/A
Revenue Growth
1.05
181.46
52 Week Low
$35.50
$5.20
52 Week High
$47.31
$55.89

Technical Indicators

Market Signals
Indicator
ACU
KRRO
Relative Strength Index (RSI) 55.63 57.22
Support Level $40.48 $12.98
Resistance Level $46.89 $15.00
Average True Range (ATR) 1.34 1.02
MACD 0.08 0.04
Stochastic Oscillator 65.97 50.34

Price Performance

Historical Comparison
ACU
KRRO

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About KRRO Korro Bio Inc.

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.

Share on Social Networks: